7.3.06: Biotechnology Report
A roundtable forum, 3 analysts and top management from 13 firms examine the Biotechnology sector in this 67 page report from The Wall Street Transcript.

  1. Roundtable Forum: Outlook for Biotechnology - Biren Amin, Stanford Group Company; Shiv Kapoor, Montgomery & Co.

  2. Small & Mid-Cap Oncology Companies: Reni Benjamin, Rodman & Renshaw

  3. Antiviral & Antibacterial Drug Companies: Edward Nash, Stifel, Nicolaus & Company

  4. Pulmonary Arterial Hypertension: Andrew Fein, C.E. Unterberg, Towbin

  5. CEO Interviews (average 2,500 words): Top management from 13 firms examine the outlook for their firm and sector. Firms interviewed include: Aastrom Biosciences, Aethlon Medical, Amarillo Biosciences, BioCryst Pharmaceuticals, CytRx Corporation, Endologix, Human Genome Sciences, MultiCell Technologies, Nanogen, Onyx Pharmaceuticals, Pharmos Corporation, Sanguine Corporation and Sequenom.

    Topics covered: Sector trial failures - FDA approval trends - Equity financing models - M&A activity - European Union regulations - Cancer drugs - Infectious diseases - HCV space

     Companies covered: Cardiome Pharma (CRME), Neurocrine (NBIX), NitroMed (NTMD), Amylin (AMLN), Myriad Genetics (MYGN), Sangamo BioSciences (SGMO), Callisto Pharmaceuticals (KAL), AEterna Zentaris (AEZS), Bioenvison (BIVN), Spectrum Pharmaceuticals (SPPI), Novartis (NVS), Genentech (DNA), Panacos (PANC), Idenix (IDIX), Vertex (VRTX), Myogen (MYOG) and Insmed (INSM).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE